DoW Lung Cancer Patient-Centered Outcomes and Survivorship Award

This program funds high-risk, high-reward research to improve lung cancer outcomes and survivorship, including quality of life, symptom management, resilience, comorbid conditions, and other patient-centered topics. Applicants must include a lung cancer patient/survivor or caregiver as an advocate on the research team, and all projects must address at least one FY26 lung cancer health outcomes and survivorship area of emphasis. U.S. Department of War organizations, foreign and domestic organizations, and for-profit or nonprofit and public or private entities may apply; the principal investigator must be an independent investigator, and awards are made to organizations, not individuals. The program expects to fund about two awards at up to $975,000 total costs each for up to 3 years, with no cost-sharing requirement. There are no stated geographic restrictions, but the program strongly emphasizes relevance to military, Veteran, and family health populations and related resources.

✳ AI-generated summary — verify against the announcement

• Science and Technology and other Research and Development
• Research & Discovery
• Patients & People with Health Conditions
• Researchers & Scholars
• Biomedical & Disease Research
• Health Care Delivery, Access & Workforce

• ✓ Unrestricted